The 19% THC flower costs $5.97 per gram. The 25% THC flower costs $10.99. Which one gives me the most bang for my buck? Many of us failed those math problems in middle school. So why do we sell cannabis this way?
White paper with Technobis on the use of Crystal16 to develop crystallization conditions for CBD.
We ask the industry to stop complaining and to start evolving into a saner, better version of themselves. We give specific advise on five different areas to improve.
We developed an algorithm to improve heavy metal testing throughput and costs by combining sample batches into pools.
Different milling instruments and conditions were compared to investigate the effect of different milling protocols on cannabinoid recovery. It was found that a Fritsch Pulverisette 11 with a single use container shows comparable to higher recoveries of cannabinoids, while having the added benefits of protecting against cross contamination and reducing cleaning time and costs.
Fritsch milling equipment is an alternative to uncontrolled milling for sample preparation. Here we show a general method and assay for volatile constituents of functional mushroom extracts can be dramatically affected by milling conditions.
In this article, Markus Roggen demonstrates a new method for recapturing terpenes lost during the cannabis extraction process. Terpenes provide cannabis with distinctive aromas and flavors that are often desired by the consumer. During the cannabis drying and decarboxylation stages, up to 30% of terpenes are lost along with the water phase from the product…
In many ways, major Cannabis companies are like pharmaceutical companies. They produce and sell products used for medicinal purposes, and their main pages have statements on how science is the most important thing in their work. We looked at 10 major pharmaceutical companies, and 10 major cannabis companies, and compared what positions they had for scientists, and their R&D spending. Unlike pharmaceutical companies, cannabis companies rarely have any scientists in the executive suites. Further, R&D spending from most of the cannabis companies we looked at was below 5% of their annual income (less than many agricultural companies), indicating these companies are not putting their money where their mouth is.
Following the release of footage showing a patient in a study conducted by MAPS being inappropriately touched by two therapists, all Health Canada-approved MDMA trials have been halted for review. Multiple other participants have come forward with negative experiences, practitioners have pointed out flaws in the therapeutic techniques being used, and scientists have pointed out mishandlings of data representation in publications put out by research groups. As critical supporters of psychedelic research, we point out ways we can improve to ensure it is being done in the most ethical way possible and to ensure the industry survives as more than just another fad.
Compass Pathways was granted a patent for what they claim to be a newly discovered crystalline form of psilocybin. This patent would allow Compass to exclude others from benefitting from the use of that crystalline form. That patent was challenged in court due to ambiguous scientific jargon and, more critically, because Polymorph A is not a new polymorph at all. We explain what crystal polymorphs are, why finding new polymorphs is significant, and why scientists are able to claim this new crystal structure not new at all.
Everyone, right now, wants to know how much psilocybin and psilocin are in the mushroom. That, we can do. But here at delic labs we are also looking at the full suite of other compounds in magic mushrooms.
It turns out the percent total THC on your cannabis package is not accurate- in fact, you have a little more THC in your products than you thought. So, what does this mean for those in the hemp and cannabis industry?
Magic mushroom tea- is it a good idea? (From a chemical point of view of course) Our expert chemists Dr. Roggen and Dr. Janusson weigh in their thoughts.
At Delic Labs, we propose a guide, the Cannabis Better Future (CBF) concept, that illustrates the different pillars the cannabis industry should adopt to improve the economic and environmental sustainability of the industry.
You’ve probably heard of the entourage effect with cannabis. Since psilocybin mushrooms also have terpenes, does that also mean they have an entourage effect?
In this op-ed, Dr. Roggen et al. propose a system for websites like Leafly that would allow its users to share revenue from their content and personal data, enabling a higher sense of trust, credibility and ultimately more value for every stakeholder involved. Using NFTs, they suggest consumers in the cannabis industry could generate a product and benefit from it too
Psilocybin and the active (makes you trip) molecule psilocin are rarely studied in analytical labs. As a result, there were no validated methods to determine the purity of these samples- until we made one.
Vape injuries occurred in 2019 because of THC adulterated with tocopherols (a vitamin derivative.) To prevent some issues before market, a lab can test cannabis oil for certain contaminants to determine how toxic a vape pen is. But how does a lab quantify a stream of aerosolized vapor or smoke?
Increasingly, data is seen as the holy grail of a modern business. Data evangelism has swept the media. Dr. Tom Dupree explains why this is a problematic way of thinking. “Useful data can be turned into insight; useless data is an opportunity loss.”
Sometimes, cannabis is a gateway drug—and in the case of chemical research, that might not be a bad thing. Our research with cannabis served as a training ground to get us ready to work with psilocybin mushrooms.
The poisonous chemical components of molds found in crops like cannabis, wheat, rice, and corn are called mycotoxins. Mycotoxins are a huge problem in cannabis, but they are difficult to detect. Here we explain some of the analytical challenges of mycotoxin detection in cannabis and what is required moving forward.
In this written Q&A, Dr. Roggen discusses the importance of understanding psilocybin’s chemistry, getting licensed to research psilocybin by Health Canada, and the similarities and differences of cannabis vs. psilocybin research. The interview also covers psilocybin’s growing prevalence and popularity, the unknowns that researchers hope to understand, and more!
The 2018 Farm bill legalized any cannabis and related products with less than 0.3% delta 9 THC, leaving a loophole for products with the intoxicating delta 8 THC, which is both naturally occurring and can be made from CBD. This has left those in the market wondering if delta 8 products will be a threat to those in the delta 9 market, or if it will be another opportunity.
In the beginning, a German Chemist wanted to start his own company. Dr. Markus roggen explains the genesis of DELIC Labs (formerly cbdv)
Unadulterated cannabis concentrates can contain unknown substances depending on how they were produced. One compound that recently appeared is known as Delta-10-THC, an almost entirely unexplored form of THC. The cannabinoid has only been discovered after cannabis was highly processed, although it is touted as plant-derived by some companies. So, is delta-10-THC natural or synthetic?
